EUVIMEDEUVIMED entdecken
Crossref

Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication

Ying Li, Yu-Yang Zhou, Chang-Ping Li, Mei Xu, Lian Hu

World Journal of Gastroenterology · 17.11.2026

DOI: 10.3748/wjg.126600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 17.11.2026. Verfasst von Ying Li und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, Y., Zhou, Y., Li, C., Xu, M., & Hu, L. (2026). Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.126600

Vancouver

Li Y, Zhou Y, Li C, Xu M, Hu L. Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.126600

BibTeX
@article{Li2026,
  author = {Li, Ying and Zhou, Yu-Yang and Li, Chang-Ping and Xu, Mei and Hu, Lian},
  title = {Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication},
  journal = {World Journal of Gastroenterology},
  year = {2026},
  doi = {10.3748/wjg.126600}
}
Kostenlos starten →